Evidence map›Paper›PMID 34395585›Full record

ReviewMicrobial cell (Graz, Austria)2021

Exploring

Christina S Moesslacher, Johanna M Kohlmayr, Ulrich Stelzl

Open access · goldAbstract readReview
In one paragraph

Review in Microbial cell (Graz, Austria), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Journal of proteome research · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christina S MoesslacherInstitute of Pharmaceutical Sciences and BioTechMed-Graz, University of Graz, Graz, Austria.
Johanna M KohlmayrInstitute of Pharmaceutical Sciences and BioTechMed-Graz, University of Graz, Graz, Austria.
Ulrich StelzlInstitute of Pharmaceutical Sciences and BioTechMed-Graz, University of Graz, Graz, Austria.
University of Graz · AT

Funding

Austrian Science Fund FWF DOC 50Austrian Science Fund FWF P 30162Austrian Science Fund FWF P 34316
6 · The paper itself

Abstract

Yeast is a valuable eukaryotic model organism that has evolved many processes conserved up to humans, yet many protein functions, including certain DNA and protein modifications, are

Indexed as

cancer mutationsdeep mutational scanningDNA methylationmassively parallel reporter assaysphosphorylationprotein-protein interactionyeast two-hybrid

Identifiers

PMID34395585
PMCPMC8329848
OpenAlexW3191014580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.